Conference Coverage
about 6 hours ago
Day 1 Recap: Elevate-Derm Fall Conferenceabout 10 hours ago
Brian Kim, MD, MTR, FAAD, on the Power of Focus in Researchabout 16 hours ago
Previewing the 2025 Elevate-Derm Fall ConferenceLatest News
Nov 13, 2025 | Feature
Day 1 Recap: Elevate-Derm Fall Conference
Topical and Systemic Tools Expand Options for Hair Loss, Pigmentary Disorders, and Hand Eczema
Nov 13, 2025
Brian Kim, MD, MTR, FAAD, on the Power of Focus in Research
Nov 13, 2025
Arcutis Completes Enrollment in Phase 2 Study of Roflumilast Cream for Infant AD
Nov 13, 2025
Dupilumab Demonstrates Positive Effects on TCS Use, Growth in Pediatric Patients
Nov 13, 2025
Advertisement
Shorts
0:13
Breast Cancer Care by Dermatologists: A Year-Round Commitment
10 days ago
by
Christopher G. Bunick, MD, PhD
0:34
Leave the Ladder Down: Mentoring the Next Generation
11 days ago
by
Lauren Miller, PA-C(+1 more)
0:30
Why Breast Cancer Patients Must Get Routine Skin Exams
13 days ago
by
Christopher G. Bunick, MD, PhD
1:00
New Oral Treatments to Revolutionize Psoriasis Care
14 days ago
by
Ronald Vender, MD, FRCPC
0:53
From Consultation to Transformation: Emphasizing Strategic Aesthetics at PDPA 2025
a month ago
by
Kachiu C. Lee, M.D.
0:42
Supporting Skin Health in the Prejuvenation Era
a month ago
by
Amy B. Lewis, MD
0:30
What Makes APG777 a Potential First-line Therapy?
a month ago
by
Emma Guttman-Yassky, MD, PhD
0:59
Treating Dermatological Diseases As Processes
a month ago
by
Brian Kim, MD
0:31
Fighting Misinformation on Injectables and HA Fillers
a month ago
by
Lisa Espinoza, MD
0:59
How Dermatologists Can Best Support Patients With BFRBs
a month ago
by
Sofia Wenzler, PhD
Podcasts
Dermatology Times Digital Edition
Experts discuss essential skin care strategies for sensitive skin, emphasizing evidence-based cleansing and moisturizing to restore the compromised skin barrier.
Experts discuss effective strategies for managing facial hyperpigmentation, emphasizing personalized treatment plans and the importance of sun protection.
Experts discuss icotrokinra's potential to revolutionize psoriasis treatment with oral therapies, emphasizing efficacy, safety, and patient-centered care at EADV 2025.
In a recent Dermatology Times custom video series, Zoe Diana Draelos, MD, and Cheri Frey, MD, discussed evidence-based cleansing and moisturizing practices for sensitive skin.
ORKA-001 by Oruka Therapeutics offers promising yearly dosing for psoriasis, showcasing extended efficacy and safety in early clinical trials.
Skin pain in atopic dermatitis significantly impacts quality of life, necessitating its recognition and treatment as a vital symptom for better patient outcomes.
Explore the latest FDA approvals in dermatology, including treatments for eczema and psoriasis, and gain insights on chronic spontaneous urticaria.
Christopher Bunick, MD, PhD, emphasizes how dermatologists can improve outcomes through vigilant skin exams and collaborative care with oncology teams.
Discover the latest advancements in CSU therapy, including Gil Yosipovitch's insights on barzolvolimab's promising results and its potential impact on patient care.
Onco-dermatology enhances patient care and quality of life by addressing skin toxicities in breast cancer treatments through expert management and collaboration.
Continuing Medical Education
All News
Advertisement
Advertisement
The study supports the hypothesis that targeting oxidative stress could complement phototherapy in restoring pigmentation in vitiligo.
Matthew Brunner, MHS, PA-C, discusses upcoming highlights of the 6th annual meeting for dermatology NPs and PAs.
The exclusive event brought together physician assistants and nurse practitioners from across the country to review complex atopic dermatitis, psoriasis, chronic hand eczema, and hidradenitis suppurativa patient cases.
Marc Serota, MD, notes that areas lacking hair follicles respond more slowly to therapy and benefit from long-term, low-risk use of topical ruxolitinib.
Explore the latest advancements and expert insights from the SDPA Fall 2025 Meeting held in San Antonio, Texas.
Nemolizumab shows significant efficacy in reducing pruritus and improving skin clearance in patients with prurigo nodularis, offering new therapeutic hope.
Karan Lal, DO, explores the transformative role of GLP-1 therapies in dermatology, highlighting their potential in treating inflammatory skin diseases and enhancing aesthetic care.
Experts discuss essential skin care strategies for sensitive skin, emphasizing evidence-based cleansing and moisturizing to restore the compromised skin barrier.
Shannon Trotter, DO, and Renata Block, DMSc, MMS, PA-C, discuss social media's impact on dermatology, highlighting trends, misinformation, and the need for clinician engagement.
Lindsay Ackerman, MD, FAAD, shares practical insights on managing vitiligo with topical ruxolitinib, addressing patient expectations, safety, and evolving research gaps.
Advertisement
FDA updates labeling for menopausal hormone therapy, removing broad boxed warnings and adding guidance for younger symptomatic patients.
Joseph Gatti, DMSc, MPAS, MBA, PA-C, discusses the impact of social media and AI on dermatology, urging professionals to adapt and educate in a rapidly evolving landscape.
Experts discuss effective strategies for managing facial hyperpigmentation, emphasizing personalized treatment plans and the importance of sun protection.
Heather Goff, MD, MPH, discusses her role as SDPA Medical Director and the vital collaboration between dermatology PAs and physicians at the 2025 fall conference.
The first-in-class mast cell–selective c-Kit inhibitor ALY-301 enters clinical testing for cold urticaria in Germany.
Advertisement
Advertisement
Trending on Dermatology Times
1
Dupilumab Demonstrates Positive Effects on TCS Use, Growth in Pediatric Patients
2
Arcutis Completes Enrollment in Phase 2 Study of Roflumilast Cream for Infant AD
3
Pilot Study Tests Oral NAC as Adjunct in Vitiligo Therapy
4
Topical and Systemic Tools Expand Options for Hair Loss, Pigmentary Disorders, and Hand Eczema
5
